NEW YORK (GenomeWeb News) – GeneNews on Friday reported a 66 percent decline in second-quarter revenues but narrowed its loss compared to the year-ago period.

For the three months ended June 30, the Toronto-based diagnostics developer recorded revenue of C$100,000 (US$90,078) compared to C$300,000 (US$270,263) in the comparable period of 2008.

The company's net loss improved to C$1.8 million, or C$0.03 per common share, compared to C$4 million, or C$0.07 per common share for the second quarter of 2008.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Congress approved a bill Friday that would increase the US National Institutes of Health's funding by $2 billion for fiscal year 2019.

Sarah Lawrence College's Laura Hercher warns in a New York Times op-ed that more people are going to need help figuring out what their consumer genetic testing results mean.

UK's Labour Party calls for a ban on non-invasive prenatal testing for determining sex, BBC News reports.

In PLOS this week: intra-tumor heterogeneity patterns, genomic analysis of Thoroughbred horse origins, and more.

Oct
02
Sponsored by
Roche

In the last few years several molecular testing methodologies — such as immunohistochemistry, PCR, and sequencing — have been approved by the US Food and Drug Administration to aid in the management of patients with lung cancer.  

Oct
11
Sponsored by
ArcherDX

This webinar will discuss a validation study for a next-generation sequencing (NGS) assay for hematological malignancies (e.g., acute myeloid leukemia, acute lymphocytic leukemia, myelodysplastic syndrome, and myeloproliferative neoplasms).